Chinese herbal medicine for subfertile women with polycystic ovarian syndrome

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Zhang, Jing ^a   Li, Tingting ^b   Zhou, Lingling ^b   Tang, Liuling ^b   Xu, Liangzhi ^b   Wu, Taixiang ^c   Lim, Danforn C E ^d  

^a LANZHOU UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

^d UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CHINESE DRUG; FOLLITROPIN; GONADORELIN; GONADOTROPIN; HERBACEOUS AGENT; HUMAN MENOPAUSAL GONADOTROPIN; INSULIN; INSULIN SENSITIZING AGENT; ORAL CONTRACEPTIVE AGENT; TRIACYLGLYCEROL;

ALTERNATIVE MEDICINE; ANDROGEN BLOOD LEVEL; BASIL; CHINESE MEDICINE; DIET; DRUG EFFICACY; DRUG SAFETY; ECHOGRAPHY; EXERCISE; FEMALE INFERTILITY; HERBAL MEDICINE; HOLISTIC CARE; HORMONAL THERAPY; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVE BIRTH; MENSTRUAL CYCLE; METHODOLOGY; OUTCOME ASSESSMENT; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 70249135594     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007535     Document Type: Review

References (52)

1. Alvarez-Blasco F, Botella-Carretero JI, San Millan JL, Escobar-Morreale HF. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Archives of InternalMedicine 2006;166(19):2081-2086 (Pubitemid 44631395)
2. Berneis K, Rizzo M, Lazzaroni V, Fruzzetti F, Carmina E. Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2007;92(1):186-189 (Pubitemid 46067529)
3. Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. Ameta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Human Reproduction Update 2006;12 (6):673-683 (Pubitemid 44605508)
4. Carmina E, Lobo RA. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathies associated with significant morbidity in women. Journal of Clinical Endocrinology and Metabolism 1999;84(6):1897-1899 (Pubitemid 30647006)
5. Cong LX. [Observation of Tiaojin Zhuyun Pellet combined with clomiphene in treating infertility caused by PCOS]. Journal of Practical Traditional Chinese Medicine 2006;22(5):290-291
6. Costello M, Shrestha B, Eden J, Sjoblom P, Johnson N. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD005552.pub2] (Pubitemid 351820473)
7. Cui FY, Liu XM. [Gaoshao soup in treating 60 cases of PCOS]. Journal of Practical Traditional Chinese Medicine 2004;20(12):686-687
8. Dunaif A. Insulin resistance and the polycystic ovary syndrome mechanism and implications for pathogenesis. Endocrine Reviews 1997; 18(6):774-800. (Pubitemid 28009567)
9. Ehrmann DA, Cavaghan MK, Barnes RB, Imperial J, Rosenfield RL. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999;22(1):141-146 (Pubitemid 29028311)
10. Escobar-Morreale HF, Luque-Ramirez M, San Millan JL. Themolecular genetic basis of functional hyperandrogenism and polycystic ovary syndrome. Endocrine Reviews 2005;26(2):251-282 (Pubitemid 40503471)
11. The Rotterdam ESHRE/ASRM Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 2004;19(1):41-47
12. Farquhar C, Lilford RJ, Marjoribanks J, Vandekerckhove P. Laparoscopic ??drilling?? by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD001122.pub3.] (Pubitemid 351805541)
13. Gambineri A, Pasquali R. Insulin resistance, obesity and metabolic syndrome in polycystic ovary syndrome. Endocrinol Nutr 2006;53 (S1):49-55. (Pubitemid 47216085)
14. Higgins JPT, Thompson SG. Quantifying heterogeneity in a metaanalysis. Statistics in Medicine 2002;21(11):1539-1558
15. Higgins JPT, Green S, editors. Application of quality assessment criteria. CochraneHandbook for Systematic Reviews of Interventions 4.2.5[updated May 2005]; Section 6.9. In: The Cochrane Library, Issue 3. Chichester, UK: John Wiley & Sons, Ltd, 2005.
16. House of Lords Select Committee. Science and Technology ? - Sixth Report: COMPLEMENTARY AND ALTERNATIVE MEDICINE. http://www.publications.parliament.uk/ pa/ld199900/ldselect/ldsctech/123/12303.htm#a32000.
17. International Conference on Harmonisation Expert Working Group. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice. CFR& ICH Guidelines. 1st Edition. USA: Barnett International/PAREXEL, 1997:19063-22043
18. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al.Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1): 1-12. (Pubitemid 26120810)
19. Jin WX, Sun SX, Wang CY. [Research on Luole in treating female ovulatory disorder]. Journal of Fujian College of Traditional Chinese Medicine 1986;10(2):11-13
20. Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. British Medical Journal 2001;323(7303):42-46 (Pubitemid 32682008)
21. Kjaergard LL, Villumsen J, Gluud C. Reported methodological quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135(11):982-989
22. Lampert N, Xu Y. Chinese herbal nephropathy. Lancet 2002;359 (9308):796-797
23. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome a prospective, controlled study in 254 affected women. Journal of Clinical Endocrinology and Metabolism 1999;84(1):165-169 (Pubitemid 29036695)
24. Legro RS, Kunselman AR, Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. American Journal of Medicine 2001;111(8):607-613 (Pubitemid 34088070)
25. Li XB, Li LY. [Daotan Zhongzi Fang combined with clomiphene in treating PCOS]. The Journal of Practical Medicine 2000;16(4):330-331
26. Li XB, Li LY, Huang JL, Liang XF. Effect of operation under celioscopy combined with kidney tonifying and phlegm removing herbal medicine for polycystic ovarian disease syndrome. Traditional Chinese Drug Research & Clinical Pharmacology 2002;13(2):75-6, 131.
27. Li XP. Chinese drugs of reinforcing kidney, clearing liver, and activating blood for treatment of infertility caused by polycystic ovary syndrome. Journal of Fujian College of Traditional Chinese Medicine 2005;15(4):9-11.
28. LiCP. [Effective observation on BushenTiaozhou Method in treating 30 infertility patients with PCOS].New Journal of Traditional Chinese Medicine 2006;38(1):50-51
29. Lin Y. Combinative treatment of Chinese traditional and western medicine in 48 patients with sterility due to polycystic ovarian syndrome. Maternal and Child Health Care of China 2005;20(13):1642-1643
30. Liu Y, Lu XY. [Traditional Chinese medicine in treating 12 PCOS]. New Journal of Traditional Chinese Medicine 2005;37(8):74-75
31. Lo JC, Feigenbaum SL, Escobar GJ, Yang J, Crites YM, Ferrara A. Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome a population based study. Diabetes Care 2006;29(8):1915-1917 (Pubitemid 44156652)
32. Lo JC, Feigenbaum SL, Yang J, Pressman AR, Selby JV, Go AS. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2006;91(4):1357-1363
33. Lord GM, Cook T, Arlt VM, Schmeiser HH, Williams G, Pusey CD. Urothelial malignant disease and Chinese herbal nephropathy. Lancet 2001;358(9292):1515- 1516 (Pubitemid 33055708)
34. Lord JM, Flight IHK, Norman RJ. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2003, Issue 210.1002/14651858.CD003053. [DOI: 10.1002/14651858.CD003053]
35. Moher D, Pham B, Jones A, Cook DJ, Jadad A, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analysis. Lancet 1998;352(9128):609-613 (Pubitemid 28380142)
36. Ni HY, Gong J. [Research progress on Chinese herbal medicine in treating PCOS]. Liaoning Journal of Traditional Chinese Medicine 2007;34(1):123-124
37. Ning MH, Liu YJ, Ning XG. Clinical Observation on Yishenxiaozheng Decoction for the Treatment of 85 Cases of Polycystic Ovarian Disease. Hunan Guiding Journal of TCM 2004;10(3):27-28
38. Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, et al.Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). New England Journal of Medicine 2000; 342(23):1686-1692 (Pubitemid 30354515)
39. Nugent D, Vandekerckhove P, Hughes E, Arnot M, Lilford R. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2000, Issue 3. [DOI: 10.1002/14651858.CD000410]
40. Rajkhowa M, Neary RH, Kumpatla P, Garne FL, Jones PW, Obhrai MS, et al.Altered composition of high density lipoproteins in women with the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 1997;82(10):3389-3394 (Pubitemid 27419093)
41. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions ofmethodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-412
42. Shao MX, Zhang XL, Sun JJ, Yan LF. [Clinical observation on TCM combined with western medicine in treating infertility caused by PCOS]. Journal of Sichuan of Traditional Chinese Medicine 2006;24 (1):90-91
43. Sinawat S, Buppasiri P, Lumbiganon P, Pattanittum P. Long versus short course treatment with Metformin and Clomiphene Citrate for ovulation induction in women with PCOS. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD006226.pub2] (Pubitemid 351807606)
44. Talbott I, Clerici A, Berga SL, Kuller L, Guzick D, Detre K, et al. Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome results of a case control study. Journal of Clinical Epidemiology 1998;51(5):415-422 (Pubitemid 28223308)
45. Wang ZH, Yang YS,Zhang YL.Clinical study of Ganshao Capsule in treating clomiphene-resistant polycystic ovarian syndrome. Chinese Journal of Integrated Traditional and Western Medicine 2005;25(8): 704-706
46. Wang BQ, Ling M. [Research development of Chinese herbal medicine for PCOS]. Shandong Journal of Traditional Chinese Medicine 2008;27(2):138-140
47. Xia Y. [Cangfu Daotan Soup in treating 30 obese cases with PCOS]. Tianjin Journal of Traditional Chinese Medicine 2004;21(2):169.
48. Xue XW, Wang N. [Effective observation on TCM combined with ultrasound in treating 56 PCOS]. Chinese General Practice 2004;7 (11):828.
49. Yang ZW, You ZL, Zhang XH, Wang Y, Zeng M. [Research on influence of Bushen Huoxue Method on menstrual cyclicity and reproductive hormone in PCOS]. Chinese Journal of Traditional Medical Science and Technology 2006;13(1):5-6.
50. Ye LQ. [TCM periodical therapy combined with metformin in treating 62 PCOS]. Jiangxi Journal of Traditional Chinese Medicine 2004; 35(257):22-23
51. Yuan XF. [TCM periodical treatment on 38 PCOS]. Fujian Journal of Traditional Chinese Medicine 2003;34(2):22.
52. Zhang QP. [Bushen Huoxue Method in treating PCOS]. Chinese Journal of Information on TCM 2004;11(11):1014-1015